Tumor repolarization by an advanced liposomal drug delivery system provides a potent new approach for chemo-immunotherapy-Reference-Cited by-同舟云学术

Tumor repolarization by an advanced liposomal drug delivery system provides a potent new approach for chemo-immunotherapy

Published:2020-09-04 Issue:36 Volume:6 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Ringgaard L.¹^ORCID,Melander F.¹^ORCID,Eliasen R.¹^ORCID,Henriksen J. R.¹,Jølck R. I.¹^ORCID,Engel T. B.¹^ORCID,Bak M.¹^ORCID,Fliedner F. P.²^ORCID,Kristensen K.¹^ORCID,Elema D. R.³^ORCID,Kjaer A.²^ORCID,Hansen A. E.¹^ORCID,Andresen T. L.¹^ORCID

Affiliation:

1. Department of Health Technology, Biotherapeutic Engineering and Drug Targeting, Technical University of Denmark, Kgs. Lyngby, Denmark.

2. Department of Clinical Physiology, Nuclear Medicine and PET and Cluster for Molecular Imaging, Department of Biomedical Sciences, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.

3. The Hevesy Laboratory, Center for Nuclear Technologies, Technical University of Denmark, Roskilde, Denmark.

Abstract

Liposomal oxaliplatin remodels the tumor microenvironment and potentiate TLR-agonist–mediated immune responses in cancer.

Funder

European Council of International Schools

Lundbeckfonden

Novo Nordisk Fonden

Danish Research Council for Independent Research

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary